Statin Use and Its Facility-Level Variation in Patients with Diabetes: Insight from the Veterans Affairs National Database

Clinical Cardiology

Volumn 39, Issue 4, 2016, Pages 185-191

  Pokharel, Yashashwi ^a   Akeroyd, Julia M ^b,d   Ramsey, David J ^b,d   Hira, Ravi S ^b   Nambi, Vijay ^b,c,d   Shah, Tina ^b,d   Woodard, LeChauncy D ^b,d   Winchester, David E ^e,f   Ballantyne, Christie M ^b,c   Petersen, Laura A ^b,d   Virani, Salim S ^b,c,d  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^d MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PITAVASTATIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; DIABETIC PATIENT; DRUG USE; FEMALE; HEALTH CARE FACILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PRESCRIPTION; PRIMARY MEDICAL CARE; VETERANS AFFAIRS NATIONAL DATABASE; CLINICAL PRACTICE; COMPARATIVE STUDY; DYSLIPIDEMIAS; FACTUAL DATABASE; GOVERNMENT; HEALTH CARE DISPARITY; MIDDLE AGED; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; PROTOCOL COMPLIANCE; TIME FACTOR; TRENDS; UNITED STATES; VETERANS HEALTH;

ADULT; AGED; AMBULATORY CARE FACILITIES; DATABASES, FACTUAL; DIABETES MELLITUS; DRUG PRESCRIPTIONS; DYSLIPIDEMIAS; FEMALE; GUIDELINE ADHERENCE; HEALTHCARE DISPARITIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PRACTICE PATTERNS, PHYSICIANS'; PRIMARY HEALTH CARE; TIME FACTORS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS HEALTH;

EID: 84963652884     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22503     Document Type: Article

References (21)

1. Kearney PM, Blackwell L, Collins R, et al,; Cholesterol Treatment Trialists' Collaborators. Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet. 2008; 371: 117-125.
2. American Diabetes Association. Cardiovascular disease and risk management. Diabetes Care. 2015; 38 (suppl 1): S49-S57.
3. Stone NJ, Robinson JG, Lichtenstein AH, et al., 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published correction appears in Circulation. 2014;129(25 suppl 2):S46-S48]. Circulation. 2014; 129 (25 suppl 2): S1-S45.
4. Woodard LD, Landrum CR, Urech TH, et al., Treating chronically ill people with diabetes mellitus with limited life expectancy: implications for performance measurement. J Am Geriatr Soc. 2012; 60: 193-201.
5. Woodard LD, Landrum CR, Urech TH, et al., Impact of clinical complexity on the quality of diabetes care. Am J Manag Care. 2012; 18: 508-514.
6. Beard AJ, Hofer TP, Downs JR, et al,; Diabetes Clinical Action Measures Workgroup. Assessing appropriateness of lipid management among patients with diabetes mellitus: moving from target to treatment. Circ Cardiovasc Qual Outcomes. 2013; 6: 66-74.
7. Virani SS, Woodard LD, Akeroyd JM, et al., Is high-intensity statin therapy associated with lower statin adherence compared with low- to moderate-intensity statin therapy? Implications of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guidelines. Clin Cardiol. 2014; 37: 653-659.
8. Virani SS, Woodard LD, Ramsey DJ, et al., Gender disparities in evidence-based statin therapy in patients with cardiovascular disease. Am J Cardiol. 2015; 115: 21-26.
9. Goldstein H., Multilevel Statistical Models. 4th ed. Chichester, UK: John Wiley & Sons, Ltd.; 2010.
10. Hira RS, Kennedy K, Nambi V, et al., Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry. J Am Coll Cardiol. 2015; 65: 111-121.
11. Hira RS, Kennedy K, Jneid H, et al., Frequency and practice-level variation in inappropriate and nonrecommended prasugrel prescribing: insights from the NCDR PINNACLE registry. J Am Coll Cardiol. 2014; 63 (25 part A): 2876-2877.
12. Jacobson TA, Ito MK, Maki KC, et al., National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1-executive summary. J Clin Lipidol. 2014; 8: 473-488.
13. Reiner Z, Catapano AL, De Backer G, et al,; European Association for Cardiovascular Prevention and Rehabilitation. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2011; 32: 1769-1818.
14. Anderson TJ, Grégoire J, Hegele RA, et al., 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol. 2013; 29: 151-167.
15. Shin S, Jang S, Lee TJ, et al., Association between non-adherence to statin and hospitalization for cardiovascular disease and all-cause mortality in a national cohort. Int J Clin Pharmacol Ther. 2014; 52: 948-956.
16. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academies Press; 2001.
17. American Diabetes Association. Executive summary: standards of medical care in diabetes-2012. Diabetes Care. 2012; 35 (suppl 1): S4-S10.
18. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care. 2013;(36 suppl 1): S11-S66.
19. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
20. Grundy SM, Cleeman JI, Merz CN, et al,; National Heart, Lung, and Blood Institute, AmericanCollege of Cardiology Foundation, American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines [published correction appears in Circulation. 2004;110:763]. Circulation. 2004; 110: 227-239.
21. Maddox TM, Borden WB, Tang F, et al., Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry. J Am Coll Cardiol. 2014; 64: 2183-2192.